Home/NED Biosystems/Rebecca Lambert

RL

Rebecca Lambert

Founder, CEO, and Chair

Therapeutic Areas

Oncology Infectious Disease

NED Biosystems Pipeline

Drug	Indication	Phase
NED-170	Cancer (specific types not fully specified)	Phase 1
NED-260	Broad-spectrum antiviral	Pre-clinical

Leadership Team at NED Biosystems

Timothy Brauns, MBA

Corporate Development and Operations Advisor

Michael Mansour, MD, PhD

Chief Medical Advisor - Infectious Disease

Brian Leyland-Jones, BSc, MB BS, PhD, FRACP, FRCPC

Chair, Scientific Advisory Board - Oncology

View full NED Biosystems profile